195 related articles for article (PubMed ID: 27149458)
1. Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.
Wang L; Ding Y; Wei L; Zhao D; Wang R; Zhang Y; Gu X; Wang Z
Medicine (Baltimore); 2016 May; 95(18):e3536. PubMed ID: 27149458
[TBL] [Abstract][Full Text] [Related]
2. Disease stabilization of progressive olfactory neuroblastoma (esthesioneuroblastoma) under treatment with sunitinib mesylate.
Preusser M; Hutterer M; Sohm M; Koperek O; Elandt K; Dieckmann K; Prayer D; Marosi C
J Neurooncol; 2010 Apr; 97(2):305-8. PubMed ID: 19820899
[TBL] [Abstract][Full Text] [Related]
3. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
Czapiewski P; Kunc M; Haybaeck J
Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
[TBL] [Abstract][Full Text] [Related]
4. Treatment and outcome in 12 cases of olfactory neuroblastoma at Mexico´s National Cancer Institute: A retrospective clinical analysis and literature review.
Navarro-Fernández JO; Serrato-Avila JL; Hernández-Varela M; Tejada-Pineda MF; Hernández-Reséndiz RE; Monroy-Sosa A; Cacho-Díaz B; Herrera-Gómez Á; Reyes-Soto G
Cir Cir; 2020; 88(4):453-460. PubMed ID: 32567594
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
Topcagic J; Feldman R; Ghazalpour A; Swensen J; Gatalica Z; Vranic S
PLoS One; 2018; 13(1):e0191244. PubMed ID: 29324814
[TBL] [Abstract][Full Text] [Related]
6. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma.
Papadaki H; Kounelis S; Kapadia SB; Bakker A; Swalsky PA; Finkelstein SD
Am J Surg Pathol; 1996 Jun; 20(6):715-21. PubMed ID: 8651351
[TBL] [Abstract][Full Text] [Related]
7. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
8. Targeted 595-gene genomic profiling demonstrates low tumor mutational burden in olfactory neuroblastoma.
Friedman J; Schumacher JK; Papagiannopoulos P; Al-Khudari S; Tajudeen BA; Batra PS
Int Forum Allergy Rhinol; 2021 Jan; 11(1):58-64. PubMed ID: 32558242
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Olfactory Neuroblastoma in Remote Leptomeninges, Mimicking Intracranial Meningioma.
Kim YS; Jung S; Jang WY; Lee KH; Moon KS; Kim IY
World Neurosurg; 2016 Dec; 96():612.e9-612.e14. PubMed ID: 27609444
[TBL] [Abstract][Full Text] [Related]
11. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
[TBL] [Abstract][Full Text] [Related]
12. Olfactory Neuroblastoma with Divergent Differentiation: An Unusual Histologic Finding in a Rare Tumor.
Meyer C; Hamersley ERS; Manosalva RE; Torske K; McIntyre N; Mitchell A
Head Neck Pathol; 2017 Dec; 11(4):531-536. PubMed ID: 28168398
[TBL] [Abstract][Full Text] [Related]
13. Treatment modalities and outcomes of olfactory neuroblastoma.
Song CM; Won TB; Lee CH; Kim DY; Rhee CS
Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
[TBL] [Abstract][Full Text] [Related]
14. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
[TBL] [Abstract][Full Text] [Related]
15. Subdural extension of recurrent olfactory neuroblastoma. Case report.
Murakami M; Kakita K; Kimura S; Hosokawa Y
Neurol Med Chir (Tokyo); 2005 Nov; 45(11):596-9. PubMed ID: 16308521
[TBL] [Abstract][Full Text] [Related]
16. Mixed Olfactory Neuroblastoma and Adenocarcinoma with In Situ Neuroendocrine Hyperplasia.
Attwood JE; Jeyaretna DS; Sheerin F; Shah KA
Head Neck Pathol; 2020 Sep; 14(3):792-798. PubMed ID: 31388897
[TBL] [Abstract][Full Text] [Related]
17. Esthesioneuroblastoma: a case report of diffuse subdural recurrence and review of recently published studies.
Capelle L; Krawitz H
J Med Imaging Radiat Oncol; 2008 Feb; 52(1):85-90. PubMed ID: 18373833
[TBL] [Abstract][Full Text] [Related]
18. Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.
Taraszewska A; Czorniuk-Sliwa A; Dambska M
Folia Neuropathol; 1998; 36(2):81-6. PubMed ID: 9757618
[TBL] [Abstract][Full Text] [Related]
19. Olfactory neuroblastoma behavior inside and outside the olfactory cleft.
Jankowski R; Russel A; Gallet P; Henrot P; Vignaud JM; Nguyen DT
Surg Radiol Anat; 2015 Jul; 37(5):507-15. PubMed ID: 25218517
[TBL] [Abstract][Full Text] [Related]
20. Odorant receptor genes are expressed in olfactory neuroblastoma.
Gonzalez-Kristeller DC; Gutiyama LM; Campos AH; Soares FA; Brentani H; Malnic B
Genet Mol Res; 2013 Sep; 12(3):3479-87. PubMed ID: 24065686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
